Navigation Links
Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH
Date:12/8/2008

CHESHIRE, Conn., Dec. 8 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today reported positive results from AEGIS, an open-label registration study examining Soliris(R) (eculizumab) treatment of Japanese patients with paroxysmal nocturnal hemoglobinuria (PNH). The pre-specified primary efficacy endpoint of change in hemolysis was achieved with an 86 percent reduction (P<0.001). Key secondary endpoints including fatigue (P<0.001) and transfusions/anemia (P<0.001) were also achieved.

Top-line results from AEGIS were presented today at the 50th Annual Meeting of the American Society of Hematology in San Francisco in a poster session titled, "Safety and Efficacy of the Terminal Complement Inhibitor Eculizumab in Japanese Patients with Paroxysmal Nocturnal Hemoglobinuria: AEGIS Phase II Clinical Study Results." The study was conducted to evaluate the safety and efficacy of Soliris in Japanese patients with PNH relative to the previously reported SHEPHERD and TRIUMPH (1,2) Phase III Soliris trials, which were conducted in the United States, Europe and Australia.

"These results show clinical improvements from eculizumab for Japanese patients with PNH, consistent with those observed in the clinical trials conducted in the United States and Europe," said Yuzuru Kanakura, M.D., Ph.D., Professor of Hematology and Oncology at Osaka University Hospital in Suita, Japan, and lead author of the study. "Consistent with the results from the SHEPHERD and TRIUMPH trials, these patients experienced significant reductions in hemolysis, anemia, transfusion dependence, and fatigue. Perhaps most noteworthy was the improvement in kidney function observed with eculizumab treatment. These are important and potentially life-changing improvements for patients with PNH."

Clinical Data

In t
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody
2. Alexion Completes Enrollment in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
3. Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
4. Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin
5. GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP
6. Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinsons Disease
7. GEN Reports on the Trend Toward Predictive Toxicogenomics
8. Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
9. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
10. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
11. Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Calif. , July 10, 2014  Breg, ... and services, has launched the FreeRunner™ knee brace ... who suffer from patella mal-tracking return to active ... differently than other braces, providing support when patients ... normally when they don,t. Patellofemoral issues ...
(Date:7/10/2014)... , July 10, 2014  BC Technical, the ... MiE America , Inc., a leading provider of ... into a long-term agreement naming BC Technical as the ... MiE and BC Technical announced today ... to establish BC Technical as the service and systems ...
(Date:7/10/2014)... 10, 2014   LabStyle Innovations Corp . ... announced the appointment of Professor Richard B. ... Board of Directors. Prof. Stone brings ... to LabStyle as an entrepreneur, venture capitalist public, ... governance expert. He currently serves on the board ...
Breaking Medicine Technology:Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4
... MORRISTOWN, N.J., Sept. 15, 2011 Actavis, an international ... FDA approval of Levetiracetam Extended-Release Tablets, a generic equivalent ... Keppra XR® had US total sales of approximately ... 2011, according to IMS Health.   ...
... Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce ... Breast Endoscopy sales for the period of June through ... recently reported an increase in demand for its new ... line, designed exclusively for breast endoscopy, has become crucial ...
Cached Medicine Technology:Actavis Launches Generic Keppra XR® Tablets in the U.S. 2Solos Endoscopy Reports 32% Increase in Breast Endoscopy Sales 2
(Date:7/13/2014)... 2014 According to the Kidney Disease Solution ... by step guide on what to do to eliminate the ... Vkool writes in its review that readers can easily learn ... revitalize their kidney health. Vkool also informs in its Kidney ... their damaged kidney functions naturally. The book consists of a ...
(Date:7/13/2014)... Hills, California (PRWEB) July 13, 2014 ... Danny Musico has formed a promotional partnership with Aqua ... plant based Omega-3 EPA supplement . The collaboration ... is a celebrity fitness trainer , actor, model, ... Hollywood’s go-to trainer for A-List celebrities, he has prepared ...
(Date:7/13/2014)... 13, 2014 If Dr. Lawrence Power has ... just launched at http://www.HealthYourself101.com will expand people’s understanding ... , Power has set out to provide a health education ... actually – dare we say it? – entertaining to dig ... “aims to engage the remote learner – the solitary individual ...
(Date:7/13/2014)... Recently, iFitDress.com, one of the most popular suppliers of ... a new selection of beautiful evening dresses ... promotion for these evening gowns. Now, everybody can enjoy ... thousands of graceful gowns in its online store. Most ... Italy and many other countries. They are highly appreciated ...
(Date:7/12/2014)... 13, 2014 Recently, iFitDress.com, one of the ... of red evening gowns . What’s more, all these ... off. , The company’s senior spokesman states, “We are proud ... our website is an enjoyable shopping experience. In addition to ... online store, low prices do not always mean bad quality. ...
Breaking Medicine News(10 mins):Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 2Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 3Health News:Celebrity Fitness Expert Supports Revolutionary New Health Supplement 2Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 2Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 3Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 4Health News:New and Beautiful Evening Dresses Unveiled by iFitDress.com 2Health News:Discounted Red Evening Gown Announced by iFitDress.com 2
... for proper embryo development and disorders in these cellular ... palate, spina bifida, reports a new study. The research ... Health Sciences Center, and the Howard Hughes Medical Research ... titled ‘p38 and a p38-Interacting Protein Are Critical for ...
... with using dummy due to different developmental, hygienic or aesthetic ... that dummies are bad for babies and parents should be ... of 20 studies conducted over the world since from past ... to dummies are prone to reject or breastfeed for a ...
... Tykerb, the new experimental breast cancer treatment drug has proved ... success alone the drug might be made //available to patients ... is approved by the regulators. ,It is speculated ... the world's biggest cancer conference in Atlanta today with information ...
... has called for establishment of a global tracking ... the globe, including scientific bodies // , farmers' ... to check spread of thehunters, bird watchers . ... the UN Food and Agriculture Organisation (FAO) and ...
... commitment' to the global fight against HIV/AIDS, India ... // and discrimination against victims and expand its ... girls. ,'The soundness of India's strategy ... in Tamil Nadu which had high incidence of ...
... from heart problems, but have depression take longer to ... treadmill stress test, according to a new study published ... Joel W. Hughes, of Kent State University, Ohio, and ... from the stress test have increased mortality risk. Heart ...
Cached Medicine News:Health News:GSK’s New Anticancer Drug A Huge Success In Drug trail 2
Intermittent catheter...
Intermittent catheter...
Intermittent catheter...
... The new Finnpipette Focus from Thermo Labsystems ... uncompromising performance. Advanced features such as ... fine volume adjustment on microvolumes help to ... single channel pipettes. The new interchangeable handle ...
Medicine Products: